Literature DB >> 8185369

High dose gammaglobulin treatment for atopic dermatitis.

H Kimata1.   

Abstract

Patients with both severe atopic dermatitis and Kawasaki disease or idiopathic thrombocytopenic purpura were treated with high dose intravenous gammaglobulin. There was a marked improvement in the dermatitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185369      PMCID: PMC1029789          DOI: 10.1136/adc.70.4.335

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels.

Authors:  M Boguniewicz; H S Jaffe; A Izu; M J Sullivan; D York; R S Geha; D Y Leung
Journal:  Am J Med       Date:  1990-04       Impact factor: 4.965

2.  Topical cromolyn (disodium cromoglycate) solution in the treatment of young children with atopic dermatitis.

Authors:  H Kimata; M Igarashi
Journal:  Clin Exp Allergy       Date:  1990-05       Impact factor: 5.018

3.  High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

Authors:  P Imbach; S Barandun; V d'Apuzzo; C Baumgartner; A Hirt; A Morell; E Rossi; M Schöni; M Vest; H P Wagner
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

4.  High-dose intravenous gammaglobulin for Kawasaki disease.

Authors:  K Furusho; T Kamiya; H Nakano; N Kiyosawa; K Shinomiya; T Hayashidera; T Tamura; O Hirose; Y Manabe; T Yokoyama
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

5.  Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells.

Authors:  H Kimata; A Yoshida; C Ishioka; I Lindley; H Mikawa
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

  5 in total
  4 in total

1.  Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Childhood Atopic Dermatitis.

Authors:  Sue-Jung Jee; Joo-Hwa Kim; Hey-Sung Baek; Ha-Baik Lee; Jae-Won Oh
Journal:  Allergy Asthma Immunol Res       Date:  2011-02-14       Impact factor: 5.764

2.  Use of intravenous immunoglobulin in the treatment of childhood atopic dermatitis.

Authors:  Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Allergy Asthma Immunol Res       Date:  2011-03-21       Impact factor: 5.764

3.  Intravenous immunoglobulin treatment in a child with resistant atopic dermatitis.

Authors:  Hyuck Hoon Kwon; Kyu Han Kim
Journal:  Ann Dermatol       Date:  2012-02-02       Impact factor: 1.444

Review 4.  Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities.

Authors:  Hassan Hashemi; Masoumeh Mohebbi; Shiva Mehravaran; Mehdi Mazloumi; Hamidreza Jahanbani-Ardakani; Seyed-Hossein Abtahi
Journal:  J Res Med Sci       Date:  2017-04-26       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.